Skip to main content

Table 1 Characteristics of people in the renal risk in derby cohort by number of comorbidities

From: The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study

  

Number of comorbidities

 

Characteristic

Category

0

1

2

3 or more

Total n = 1741

Total n = 78

Total n = 453

Total n = 508

Total n = 702

  

n

(row %)

n

(row %)

n

(row %)

n

(row %)

(n (% of total) unless otherwise stated)

Sex*

Male

15

(2.2)

174

(25.3)

200

(29.0)

300

(43.5)

689 (39.6)

Female

63

(6.0)

279

(26.5)

308

(29.3)

402

(38.2)

1052 (60.4)

Age*

<60

22

(17.2)

50

(39.1)

27

(21.1)

29

(22.7)

128 (7.4)

60–69

26

(5.8)

146

(32.8)

121

(27.2)

152

(34.2)

445 (25.6)

70–79

23

(3.0)

186

(24.4)

224

(29.4)

328

(43.1)

761 (43.7)

80+

7

(1.72)

71

(17.4)

136

(33.4)

193

(43.4)

407 (23.4)

Ethnicity

White

78

(5.0)

443

(26.1)

497

(29.3)

680

(40.1)

1698 (97.5)

Other

0

(0)

10

(23.3)

11

(25.6)

22

(51.2)

43 (2.5)

Index of multiple deprivation*

Quintile 1 (most deprived)

5

(3.3)

32

(21.2)

42

(27.8)

72

(47.7)

151 (8.7)

Quintile 2

27

(6.3)

103

(23.8)

118

(27.3)

184

(42.6)

432 (24.8)

Quintile 3

14

(4.3)

88

(27.0)

94

(28.8)

130

(39.9)

326 (18.7)

Quintile 4

12

(2.7)

128

(28.6)

135

(30.2)

172

(38.5)

447 (25.7)

Quintile 5 (least deprived)

20

(5.2)

100

(26.1)

118

(30.9)

144

(37.7)

382 (21.9)

Education status*

Group1 (No formal qualifications)

30

(3.2)

209

(21.9)

305

(32.0)

409

(42.9)

953 (54.7)

Group 2 (GCSE, A level, NVQ1-3)

33

(7.0)

130

(27.7)

126

(26.9)

180

(38.4)

469 (26.9)

Group 3 (1st or higher degree, NVQ 4–5)

15

(4.7)

113

(35.7)

77

(24.3)

112

(35.3)

317 (18.2)

eGFR at study entry*

Mean (SD)

57.8

(7.6)

55.8

(9.7)

51.7

(10.2)

50.3

(10.5)

52.5 (10.4)

>60

30

(7.2)

163

(39.0)

107

(25.6)

118

(28.2)

418 (24.0)

45–59

44

(4.8)

227

(24.9)

277

(30.4)

363

(39.9)

911 (52.3)

30–44

4

(1.0)

61

(15.8)

113

(29.3)

208

(53.9)

386 (22.2)

<30

0

(0)

2

(7.7)

11

(42.3)

13

(50.0)

26 (1.5)

Albuminuria - based on 2 of 3 samples*

No albuminuria

76

(5.2)

402

(27.4)

433

(29.5)

558

(38.0)

1469 (84.4)

Albuminuria A2 ≥ 3 mg/mmol but <30 mg/mmol)

2

(0.9)

45

(19.4)

66

(28.5)

119

(51.3)

232 (13.3)

Albuminuria A3 (≥30 mg/mmol)

0

(0)

6

(15.0)

9

(22.5)

25

(62.5)

40 (2.3)

Smoking*

Current

7

(8.6)

31

(38.3)

15

(18.5)

28

(34.5)

81 (4.7)

Ex-smoker

30

(3.5)

169

(19.5)

264

(30.5)

403

(46.5)

866 (49.7)

Never

41

(5.2)

253

(31.9)

229

(28.8)

271

(34.1)

794 (45.6)

BMI*

Normal or underweight

31

(8.8)

103

(29.2)

105

(29.8)

114

(32.2)

353 (20.3)

Overweight

32

(4.3)

207

(28.1)

214

(29.0)

285

(38.6)

738 (42.4)

Obese

15

(2.3)

143

(22.0)

189

(29.1)

303

(46.6)

650 (37.3)

Number of medications*

None

28

(60.9)

16

(34.8)

2

(4.4)

0

(0)

46 (2.6)

1–2

37

(15.6)

128

(53.8)

61

(25.6)

12

(5.0)

238 (13.7)

3–4

10

(2.4)

198

(46.7)

155

(36.6)

61

(14.4)

424 (24.4)

5–9

3

(0.4)

109

(13.1)

269

(32.2)

454

(54.4)

835 (48.0)

10 or more

0

(0)

2

(1.0)

21

(10.6)

175

(88.4)

198 (11.4)

  1. Conditions included: diabetes, hypertension, ischaemic heart disease, heart failure, peripheral vascular disease, cerebrovascular disease, respiratory condition, depression, painful condition, thyroid disorder, anaemia
  2. Abbreviations: GCSE General certificate of secondary education, A level advanced level, NVQ National vocational qualification, BMI Body mass index
  3. eGFR estimated glomerular filtration rate, SD standard deviation
  4. *p < 0.05 test for trend